Immunespec
1 known investors
Find your way into Immunespec
ImmuneSpecs uses immunopeptidomics (MAPPs) technology to identify peptides presented by MHC molecules, enabling precise mapping of T cell epitopes in biotherapeutics and validation of immunotherapy targets. The company serves biopharmaceutical organizations seeking advanced antigen presentation analysis.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Immunespec do?
- ImmuneSpecs uses immunopeptidomics (MAPPs) technology to identify peptides presented by MHC molecules, enabling precise mapping of T cell epitopes in biotherapeutics and validation of immunotherapy targets. The company serves biopharmaceutical organizations seeking advanced antigen presentation analysis.
- Who founded Immunespec?
- Immunespec was founded by Elise Pepermans, Kurt Boonen.
- Who are Immunespec's investors?
- Immunespec's investors include Heran Partners.